Medicine - Clinical Research Informer

The growing uses of medicinal cannabis

Pharmaceutical Technology

MARCH 6, 2024

Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.

Medicine

Top three trends in precision medicine

Pharmaceutical Technology

SEPTEMBER 19, 2024

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual differences in genes, environments, and lifestyles to drive better outcomes through medicine.

Medicine

Medicine Gene

Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine

Bio Pharma Dive

JUNE 25, 2024

The company claims it can address some of the field’s limitations with medicines delivered via messenger RNA and lipid nanoparticles.

Medicine

Medicine Genetics RNA

Roche bets on Ionis RNA medicines with neuroscience deal

Bio Pharma Dive

SEPTEMBER 27, 2023

The Swiss drugmaker is restocking its pipeline by buying into preclinical Ionis medicines for Alzheimer’s and Huntington’s diseases.

Medicine

Medicine RNA

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine.

Medicine

CARsgen and Huadong Medicine to commercialise CT053 in mainland China

Pharmaceutical Technology

JANUARY 16, 2023

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

Medicine

Medicine Gene Therapy Production Gene

Lilly and ProQR to expand genetic medicine development agreement

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Genetics

Genetics Medicine Development Gene Therapy

The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies

Pharmaceutical Technology

AUGUST 16, 2024

Genomic medicines offer new techniques for treating conditions once thought to be intractable - a world of opportunity awaits.

Genomics

Genomics Genome Medicine

GSK and Flagship Pioneering link for new medicines and vaccines

Pharmaceutical Technology

JULY 30, 2024

GSK has announced a strategic collaboration with Flagship Pioneering for the discovery and development of medicines and vaccines.

Medicine

Medicine Vaccination Vaccine Development

These microscopic tunnels are a goldmine for new medicines

Bio Pharma Dive

JUNE 27, 2024

A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.

Medicine

Medicine Drugs Research

EU Critical Medicines Act: closer to ending overreliance on Asian manufacturers

Pharmaceutical Technology

OCTOBER 28, 2024

China's virtual monopoly on the supply of many APIs could be dangerous for the security of medicine supply to Western countries.

Medicine

Medicine Manufacturing

The importance of high-quality raw materials in the development of Regenerative Medicine

Pharmaceutical Technology

FEBRUARY 28, 2024

Regulatory standards concerning raw material selection are particularly stringent when it comes to Regenerative Medicines.

Medicine

Medicine Development

An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine

Bio Pharma Dive

OCTOBER 24, 2023

Rampart Biosciences closed a Series A round that will fund its goal to develop more potent DNA-based medicines that avoid immune responses.

DNA

DNA Medicine Immune Response Development

FDA approves new ALS medicine in precedent-setting decision

Bio Pharma Dive

APRIL 25, 2023

Biogen’s drug failed the key study meant to show it can slow the nerve-destroying disease, but the drug’s effect on a protein of interest led the FDA to conditionally clear it for market.

FDA Approval

FDA Approval Medicine Protein Marketing

Researchers see new generation therapeutics to propel precision medicine

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 30, 2024

Researchers see a greater need for new generation therapeutics to propel precision medicine. The development of innovative therapeutic approaches in healthcare encompass a variety of fields, including gene therapy, personalized medicine, immunotherapy, and advanced biologics.

Medicine

Medicine Research Gene Therapy Genetics

Biotech startup Airna raises $60M for RNA editing medicines

Bio Pharma Dive

JULY 31, 2024

Launched last September, the company is working on a treatment for alpha-1 antitrypsin deficiency, which it said could enter the clinic in 2025.

RNA

RNA Medicine

GSK gives Wave a lift with genetic medicine deal

Bio Pharma Dive

DECEMBER 14, 2022

A four-year agreement between the companies comes with $170 million in cash and equity for Wave, which in recent years has dealt with clinical setbacks.

Genetics

Genetics Medicine

FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia

Bio Pharma Dive

JANUARY 16, 2024

The agency’s decision to expand use of Casgey, which won a landmark OK for sickle cell disease in December, comes more than two months ahead of schedule.

Medicine

‘No tolerance for failure’: An oral history of the first CRISPR medicine

Bio Pharma Dive

DECEMBER 10, 2023

A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. This is the story of how it came to be.

Medicine

Medicine Development

Prime Medicine raises $175M in one of the year’s largest biotech IPOs

Bio Pharma Dive

OCTOBER 20, 2022

The gene editing startup is one of less than two dozen biotech companies to debut on Wall Street this year, as the pace of IPOs remains far off last year’s trajectory.

Gene Editing

Gene Editing Medicine Gene

Eli Lilly-backed Zephyr AI secures $111m for precision medicine tech

Pharmaceutical Technology

MARCH 14, 2024

The funds will be used to expand Zephyr AI's headcount and enhance datasets.

Medicine

Gilead ADC medicine misses goal in closely watched lung cancer study

Bio Pharma Dive

JANUARY 22, 2024

Trodelvy didn’t outperform chemotherapy in a large study of people with a common lung tumor, a setback that sent company shares down by double digits.

Medicine

Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data

Bio Pharma Dive

JULY 15, 2024

Updated results show the biotech's RAS inhibitor shrank pancreatic tumors in 20% to 25% of study participants, but with high rates of side effects like rash and nausea.

Medicine

Medicine Trials Drugs

UK Agency targets blood thinners in personalised medicine pursuit

Pharmaceutical Technology

FEBRUARY 13, 2024

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.

Biobanking

Biobanking Medicine Genetics

Editas to seek partner for CRISPR medicine after lackluster study results

Bio Pharma Dive

NOVEMBER 17, 2022

While the biotech will not develop the gene editing therapy further on its own, CEO Gilmore O’Neill claimed the data are still a meaningful demonstration of what CRISPR can accomplish.

Gene Editing

Gene Editing Medicine Gene Development

Biology opens up new frontiers in medicine to cure genetic diseases: Kiran Mazumdar Shaw

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 17, 2024

Biology is opening up new frontiers in medicine. We are witnessing a revolution in healthcare, driven by advances in genetics, Omics, RNA and CRISPR gene-editing technology, to deliver precision and personalised medicine, said Kiran Mazumdar-Shaw, executive chairperson, Biocon and Biocon Biologics.

Genetic Disease

Genetic Disease Genetics Gene Editing Medicine

World’s first CRISPR medicine approved in UK for sickle cell, beta thalassemia

Bio Pharma Dive

NOVEMBER 16, 2023

Clearance of Vertex Pharmaceuticals and CRISPR Therapeutics' Casgevy in the U.K. comes ahead of expected regulatory decisions in the U.S. and Europe.

Medicine

Pelage secures funds to develop regenerative medicine for hair loss

Pharmaceutical Technology

FEBRUARY 28, 2024

Pelage Pharmaceuticals has secured $16.75m in a Series A financing round to further the development of PP405 for hair loss.

Development

Development Medicine

AI startup Basecamp allies with the Broad to dream up ‘programmable’ genetic medicines

Bio Pharma Dive

OCTOBER 9, 2024

The company, which is building a database of biological interactions found in nature, revealed $60 million in funding and a collaboration with David Liu’s lab.

Genetics

Genetics Medicine

Moderna reports ‘encouraging’ early data for one of its rare disease medicines

Bio Pharma Dive

MAY 19, 2023

The biotech, best known for its vaccine research, said its clinical trial is the first to report results of a messenger RNA therapeutic designed for intracellular protein replacement.

RNA

RNA Medicine Clinical Trials Clinical Trials

GSK and MVV launch malaria medicine in Brazil and Thailand

Pharmaceutical Technology

JULY 8, 2024

GSK and MMV have announced the launch of tafenoquine to prevent the relapse of P. vivax malaria in Brazil and Thailand.

Medicine

New AMA policies target GLP-1 coverage, corporate medicine

Bio Pharma Dive

NOVEMBER 14, 2023

The lobbying group urged broader health insurance coverage for treating obesity, including with GLP-1 agonists like Wegovy.

Medicine

Medicines access: Unlocking the immense potential in cell and gene therapy

Pharmaceutical Technology

FEBRUARY 8, 2024

Despite several ground-breaking developments, pharmaceutical and biotech companies are often reluctant to invest in cell and gene therapy.

Gene Therapy

Gene Therapy Gene Medicine Development

Actio, a precision medicine startup, launches with $55M and a mouse lab partnership

Bio Pharma Dive

SEPTEMBER 12, 2023

The two-year-old San Diego biotech is allied with The Jackson Laboratory to engineer better mouse models of the rare diseases it plans to target.

Medicine

Medicine Engineer

AVPRF pioneers evidence-based Ayurveda and integration of modern medicine

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 10, 2024

By focusing on clinical excellence, comprehensive education, and cutting-edge research, the Arya Vaidya Pharmacy Research Foundation (AVPRF) based in Coimbatore is ensuring that ayurvedic practices are validated, credible, and relevant for future generations.

Medicine

Medicine Pharmacy Research Clinical Trials

CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System

Pharmaceutical Technology

NOVEMBER 29, 2024

Automated Industrial Robotics have delivered a bespoke Just in Time PACE system to CPI’s new Medicines Manufacturing Innovation Centre.

Manufacturing

Manufacturing Medicine Clinical Trials Clinical Trials

Sickle cell patient dies in Beam study of base editing therapy

Bio Pharma Dive

NOVEMBER 5, 2024

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.

Medicine

Medicine Drugs

RNA editing: emerging from CRISPR’s shadow

Bio Pharma Dive

OCTOBER 22, 2024

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

RNA

RNA Life Science Medicine

Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines

Bio Pharma Dive

SEPTEMBER 19, 2024

GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster than by current methods with a simpler process.

Medicine

Medicine Development

Psychiatry drugs finally have pharma’s attention. Can they keep it?

Bio Pharma Dive

APRIL 8, 2024

But many development hurdles still stand in the way of new medicines for the brain. Recent biotech company acquisitions have put emerging schizophrenia treatments in focus.

Medicine

Medicine Drugs Development

A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology

Bio Pharma Dive

SEPTEMBER 4, 2024

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Drugs

Drugs Medicine

BrainStorm files ALS drug application over FDA protest

Bio Pharma Dive

MARCH 27, 2023

The medicine, a personalized stem cell treatment, will be reviewed by an FDA advisory committee sometime in the future, the company said.

Medicine

Medicine Drugs

Drug patents protect pharma profits. Track when they’ll expire here.

Bio Pharma Dive

MAY 8, 2024

This database will track key patent expiry dates for 30 top-selling medicines. Intellectual property is the foundation of the drug industry’s business model.

Drugs

Drugs Medicine

Lilly partners with AI specialist Insitro to develop metabolic medicines

Bio Pharma Dive

OCTOBER 9, 2024

The latest deal in AI drug discovery is a twist on the usual big pharma-startup collaboration model, with Insitro licensing technology and Lilly eligible for royalties.

Medicine

Medicine Licensing Licensing Development

The growing uses of medicinal cannabis

Top three trends in precision medicine

Trending Sources

Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine

Roche bets on Ionis RNA medicines with neuroscience deal

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

CARsgen and Huadong Medicine to commercialise CT053 in mainland China

Lilly and ProQR to expand genetic medicine development agreement

The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies

GSK and Flagship Pioneering link for new medicines and vaccines

These microscopic tunnels are a goldmine for new medicines

EU Critical Medicines Act: closer to ending overreliance on Asian manufacturers

The importance of high-quality raw materials in the development of Regenerative Medicine

An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine

FDA approves new ALS medicine in precedent-setting decision

Researchers see new generation therapeutics to propel precision medicine

Biotech startup Airna raises $60M for RNA editing medicines

GSK gives Wave a lift with genetic medicine deal

FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia

‘No tolerance for failure’: An oral history of the first CRISPR medicine

Prime Medicine raises $175M in one of the year’s largest biotech IPOs

Eli Lilly-backed Zephyr AI secures $111m for precision medicine tech

Gilead ADC medicine misses goal in closely watched lung cancer study

Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data

UK Agency targets blood thinners in personalised medicine pursuit

Editas to seek partner for CRISPR medicine after lackluster study results

Biology opens up new frontiers in medicine to cure genetic diseases: Kiran Mazumdar Shaw

World’s first CRISPR medicine approved in UK for sickle cell, beta thalassemia

Pelage secures funds to develop regenerative medicine for hair loss

AI startup Basecamp allies with the Broad to dream up ‘programmable’ genetic medicines

Moderna reports ‘encouraging’ early data for one of its rare disease medicines

GSK and MVV launch malaria medicine in Brazil and Thailand

New AMA policies target GLP-1 coverage, corporate medicine

Medicines access: Unlocking the immense potential in cell and gene therapy

Actio, a precision medicine startup, launches with $55M and a mouse lab partnership

AVPRF pioneers evidence-based Ayurveda and integration of modern medicine

CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System

Sickle cell patient dies in Beam study of base editing therapy

RNA editing: emerging from CRISPR’s shadow

Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines

Psychiatry drugs finally have pharma’s attention. Can they keep it?

A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology

BrainStorm files ALS drug application over FDA protest

Drug patents protect pharma profits. Track when they’ll expire here.

Lilly partners with AI specialist Insitro to develop metabolic medicines

Stay Connected